BridgeBio Pharma Inc (BBIO)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$74.46
Buy
$75.64
$1.085 (+1.46%)
Prices updated at 13 Dec 2025, 00:39 EST
| Prices minimum 15 mins delay
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 98.25 |
| 2023 | 73.71 |
| 2022 | 95.58 |
| 2021 | 95.53 |
| 2020 | 100.00 |
| 2019 | 93.84 |
| 2018 | - |
| 2017 | - |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 40.47 |
| 2024 | 22.98 |
| 2023 | 670.16 |
| 2022 | 12.59 |
| 2021 | 40.35 |
| 2020 | 381.39 |
| 2019 | 153.83 |
Price/Forward earnings (YTD)
-37.17
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -73.11 |
| 2023 | -110.00 |
| 2022 | -58.83 |
| 2021 | -65.55 |
| 2020 | -67.21 |
| 2019 | -47.53 |
| 2018 | -46.45 |
| 2017 | -31.17 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | 12.15 |
| 2019 | 1.55 |
| 2018 | 1.48 |
| 2017 | - |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.